SRPT logo

SRPT

Sarepta Therapeutics Inc.

$18.20
-$0.14(-0.76%)
36
Overall
--
Value
25
Tech
47
Quality
Market Cap
$1.78B
Volume
22.54M
52W Range
$10.42 - $138.81
Target Price
$23.75
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$1.3M$5.4M$154.6M$602.1M$380.8M$455.9M$612.4M$843.8M$1.1B$1.8B
Total Revenue
$1.3M$5.4M$154.6M$301.0M$380.8M$540.1M$701.9M$933.0M$1.2B$1.9B
COST OF GOODS SOLD
Cost of Revenue
$221.4M$-101.0K$-35.8M$-34.2M$-66.6M$-63.4M$97.0M$140.0M$150.3M$319.1M
GROSS PROFIT
Gross Profit
$1.3M$5.5M$190.4M$335.2M$447.4M$476.7M$604.8M$793.0M$1.2B$1.6B
OPERATING EXPENSES
Operating Expenses
$221.4M$272.1M$290.4M$610.5M$1.0B$1.0B$1.1B$1.3B$1.4B$1.4B
Research & Development
$146.4M$188.3M$166.7M$401.8M$734.1M$722.3M$771.2M$877.1M$877.4M$804.5M
Research Expense
$146.4M$188.3M$166.7M$401.8M$734.1M$722.3M$771.2M$877.1M$877.4M$804.5M
Selling, General & Administrative
$75.0M$83.7M$122.7M$207.8M$284.8M$317.9M$282.7M$451.4M$481.9M$557.9M
Selling & Marketing Expenses
--------------$14.6M$28.6M$32.0M
General & Administrative Expenses
$75.0M$83.7M$122.7M$207.8M$284.8M$317.9M$282.7M$451.4M$481.9M$557.9M
Salaries & Wages
$-32.1M------------------
Depreciation & Amortization
$4.7M$29.0K$1.1M$900.0K$800.0K$700.0K$700.0K$714.0K$1.6M$2.4M
Depreciation & Amortization
$4.7M$29.0K$1.1M$900.0K$800.0K$700.0K$700.0K$714.0K$1.6M$2.4M
Amortization
--$29.0K$1.1M$900.0K$800.0K$700.0K$700.0K$714.0K$1.6M$2.4M
Other Operating Expenses
$-613.0K$-801.0K$-735.0K$-2.2M$-4.3M$-6.7M$-5.5M------
OPERATING INCOME
Operating income
$-220.2M$-266.7M$-171.6M$-343.6M$-705.6M$-564.2M$-459.7M$-536.2M$-267.8M$218.1M
EBITDA
$-214.1M$-259.7M$-35.6M$-324.3M$-667.2M$-466.2M$-317.4M$-648.1M$-475.7M$316.9M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
--$1.9M$5.8M$33.7M$30.7M$59.9M$63.5M$53.2M--$18.4M
Intinc
$154.0K$507.0K$1.8M$6.8M$7.2M$3.0M$354.0K$16.5M----
Net Non-Operating Interest Income/Expense
$154.0K$-1.4M$-4.0M$-26.9M$-23.4M$-57.0M$-63.2M$25.5M$58.3M$49.0M
Other Income/Expense
$-154.0K$535.0K$-123.0M$19.0M$8.3M$-95.3M$-130.2M$-128.2M$153.8M$-156.7M
Other Special Charges
$154.0K$-535.0K$123.0M$-19.0M$-8.3M$95.3M$130.2M$-64.5M$-153.8M$156.7M
SPECIAL ITEMS
Restructring And Mn A Income
--$4.6M$3.0M$-2.2M------------
Special Income Charges
--$-4.6M$-3.0M$2.2M------$6.9M$-617.0K$2.8M
Other Impairment Of Capital Assets
------------$4.5M$2.6M----
PRE-TAX INCOME
EBIT
$-220.0M$-265.4M$-42.8M$-328.9M$-683.2M$-493.1M$-355.4M$-690.0M$-520.1M$279.2M
Pre-Tax Income
$-220.0M$-267.3M$-48.6M$-362.6M$-713.9M$-553.1M$-418.9M$-690.0M$-520.1M$260.8M
INCOME TAX
Tax Provision
----$2.1M$-692.0K$1.2M$1.1M$-168.0K$13.5M$15.9M$25.5M
NET INCOME
Net Income
$-220.0M$-267.3M$-50.7M$-361.9M$-715.1M$-554.1M$-418.8M$-703.5M$-536.0M$235.2M
Net Income (Continuing Operations)
$-220.0M$-267.3M$-50.7M$-361.9M$-715.1M$-554.1M$-418.8M$-703.5M$-536.0M$235.2M
Net Income (Discontinued Operations)
$-220.0M$-267.3M$-50.7M$-361.9M$-715.1M$-554.1M$-418.8M$-703.5M$-536.0M$235.2M
Net Income (Common Stockholders)
$-220.0M$-267.1M$20.9M$7.5M$-581.9M$-554.1M$-418.8M$-703.5M$-536.0M$235.2M
Normalized Income
$-143.0M$-169.2M$-28.6M$-363.3M$-564.0M$-436.3M--------
TOTALS
Total Expenses
$442.9M$271.9M$254.7M$576.3M$953.2M$977.5M$947.5M$1.5B$1.4B$1.7B
SHARE & EPS DATA
Average Shares Outstanding
$42.3M$48.7M$58.8M$66.3M$73.6M$78.0M$81.3M$87.6M$92.4M$95.1M
Average Shares Outstanding (Diluted)
$42.3M$48.7M$58.8M--$73.6M$78.0M$81.3M$87.6M$92.4M$107.9M
Shares Outstanding
$45.7M$54.8M$65.0M$71.3M$77.8M$79.4M$87.1M$88.0M$93.9M$97.0M
Basic EPS
--$-5.49$-0.86$-5.46$-9.71$-7.11$-5.15$-8.03$-5.8$2.47
Basic EPS (Continuing Operations)
--$-5.49$-0.86$-5.46$-9.71$-7.11$-5.15$-8.03$-5.8$2.47
Diluted EPS
$-5.2$-5.49$-0.86$-5.46$-9.71$-7.11$-5.15$-8.03$-5.8$2.34
Diluted EPS (Continuing Operations)
--------------$-8.03$-5.8$2.34
OTHER METRICS
Minority Interests
$190.3M$336.7M----------------
Other Gand A
$75.0M$83.7M$122.7M$207.8M$284.8M$317.9M$282.7M$451.4M$481.9M$557.9M
Rent And Landing Fees
$5.2M$5.6M$4.4M$7.9M------------
Restruct
--$4.6M$3.0M$-2.2M------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2SRPT$18.20-0.8%22.54M
3
4
5
6

Get Sarepta Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.